Efficacy and safety of icosapent ethyl in hypertriglyceridaemia: a recap.

Of these events, 17.2% presented in patients in the icosapent ethyl group, and 22.0% in individuals in the placebo group, a highly significant difference [hazard ratio 0.75, 95% confidence interval (CI) 0.68–0.83; P = 0.00000001]; the RRR was 25%.

also in 132,142 other papers